Niva Bupa to redeem ₹150 crore NCDs at par on Oct 9
- Niva Bupa Health Insurance schedules Debt Raising Committee meeting for October 9, 2026
- Proposal to redeem ₹150 crore in non-convertible debentures at par value
- Instruments are unsecured, subordinated, listed, and rated NCDs issued on November 15, 2021
*this image is generated using AI for illustrative purposes only.
Niva Bupa Health Insurance Company has scheduled a Debt Raising Committee meeting for Friday, October 9, 2026, to consider the redemption of ₹150 crore in non-convertible debentures. The insurer plans to exercise its call option to redeem these instruments at par value.
The redemption involves 1,500 unsecured, subordinated, listed, rated, redeemable, non-convertible debentures. These securities were originally issued on November 15, 2021. The total aggregate value of the debentures up for redemption is ₹150,00,00,000.
Meeting details and regulatory compliance
The intimation was filed with the National Stock Exchange of India and BSE Limited under Regulation 29(1)(h) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is convened by the Debt Raising Committee of the Board.
| Particulars | Details |
|---|---|
| Meeting Date | October 9, 2026 |
| Instrument Type | Unsecured, subordinated, listed, rated, redeemable, non-convertible debentures |
| Number of Units | 1,500 |
| Aggregate Value | ₹150 crore |
| Redemption Price | At par |
| Original Issue Date | November 15, 2021 |
Key terms of the debentures
The debentures subject to this proposal are characterized as unsecured and subordinated. They are also listed and rated instruments. The company intends to exercise the call option embedded in these securities to facilitate their redemption.
The notice was signed by Aparna Sharma, Company Secretary and Compliance Officer, on October 5, 2026. Copies of the communication were sent to depositories, the registrar, and the debenture trustee.
Historical Stock Returns for Niva Bupa Health Insurance Company
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.93% | -0.37% | -7.84% | +4.82% | -7.32% | +2.47% |
How will the ₹150 crore outflow for debenture redemption impact Niva Bupa's solvency margin and regulatory capital adequacy ratios in the upcoming quarter?
Given the subordinated nature of the redeemed debt, does this signal a strategic shift in Niva Bupa's capital structure toward equity or other Tier-2 instruments?
What are the implications of redeeming these specific 2021-vintage debentures at par on the company's future cost of borrowing and credit rating outlook?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
